Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States

被引：0
|
作者：
Mickaël Hiligsmann
Stuart S. Silverman
Andrea J. Singer
Leny Pearman
Jake Mathew
Yamei Wang
John Caminis
Jean-Yves Reginster
机构：
[1] CAPHRI Care and Public Health Research Institute,Department of Health Services Research
[2] Maastricht University,Division of Public Health, Epidemiology and Health Economics
[3] Cedars-Sinai Medical Center,Chair for Biomarkers of Chronic Diseases, College of Science
[4] Los Angeles and the OMC Clinical Research Center,undefined
[5] MedStar Georgetown University Hospital and Georgetown University Medical Center,undefined
[6] Radius Health,undefined
[7] Inc.,undefined
[8] University of Liège,undefined
[9] King Saud University,undefined
来源：
PharmacoEconomics | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：819 / 830
页数：11
相关论文
共 50 条
  • [1] Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
    Hiligsmann, Mickael
    Silverman, Stuart S.
    Singer, Andrea J.
    Pearman, Leny
    Mathew, Jake
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    PHARMACOECONOMICS, 2023, 41 (07) : 819 - 830
  • [2] Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed by Alendronate in US Men at High Risk of Fracture
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Pearman, Leny
    Mathew, Jake
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2582 - 2583
  • [3] COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S55
  • [4] Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures
    Hiligsmann, Mickael
    Silverman, Stuart L.
    Singer, Andrea J.
    Pearman, Leny
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [5] Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures
    Mickael Hiligsmann
    Stuart L. Silverman
    Andrea J. Singer
    Leny Pearman
    Yamei Wang
    John Caminis
    Jean-Yves Reginster
    Aging Clinical and Experimental Research, 36
  • [6] Cost-Effectiveness Analysis of Sequential Treatment with Abaloparatide Followed by Alendronate in US Women and Men with Multiple Previous Fractures
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Wang, Yamei
    Pearman, Leny
    Caminis, John
    Reginster, Jean-Yves
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3970 - 3971
  • [7] Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
    Le, Quang A.
    Hay, Joel W.
    Becker, Russell
    Wang, Yamei
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (02) : 134 - 143
  • [8] Cost-Effectiveness of Sequential Abaloparatide/Alendronate for US Women and Men With Osteoporosis and a Recent Vertebral Fracture
    Hiligsmann, Mickael
    Silverman, Stuart
    Singer, Andrea J.
    Pearman, Leny
    Wang, Yamei
    Caminis, John
    Reginster, Jean-Yves
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1257 - 1258
  • [9] COMPARISON OF THE COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE BETWEEN US WOMEN AND MEN AT INCREASED RISK OF FRACTURE
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    VALUE IN HEALTH, 2023, 26 (06) : S84 - S84
  • [10] COST-EFFECTIVENESS OF SEQUENTIAL TREATMENT WITH ABALOPARATIDE FOLLOWED BY ALENDRONATE VS ALENDRONATE MONOTHERAPY FOR THE PREVENTION OF FRACTURES IN POSTMENOPAUSAL US WOMEN AT INCREASED RISK OF FRACTURE
    Hiligsmann, M.
    Williams, S.
    Fitzpatrick, L.
    Silverman, S.
    Weiss, R. J.
    Reginster, J. Y.
    VALUE IN HEALTH, 2019, 22 : S243 - S243
12345